Share the post "Shareholding Pattern: Shareholding Pattern Bafna Pharmaceuticals Limited An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Bafna Pharmaceuticals Limited has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
---|---|---|---|---|---|
Promoters | 2.09 | 2.09 | 88.43 | 88.3 | -0.13 % |
Public | 0.27 | 0.28 | 11.57 | 11.7 | +0.13 % |
DII | 0 | 0 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 0 |
Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 88.43% in December 2023 to 88.3% in March 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 11.57% in December 2023 to 11.7% in March 2024.This change suggests that the public’s investment in the company grew during the quarter.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
SASIKALA BAFNA | 0 | 0.000 | 0 | 0.01 | +0.01% |
SRJR LIFESCIENCES LLP | 0 | 2.079 | 0 | 87.86 | +87.86% |
SASIKALA BAFNA. | 0.000 | 0 | 0.01 | 0 | -0.01% |
SRJR Lifesciences LLP | 2.082 | 0 | 87.99 | 0 | -87.99% |
SASIKALA BAFNA had no shares in the previous quarter but now holds 0.01% of shares in the current quarter.SRJR LIFESCIENCES LLP had no shares in the previous quarter but now holds 87.86% of shares in the current quarter.SASIKALA BAFNA. had 0.01% of shares in the previous quarter but exited in the current quarter.SRJR Lifesciences LLP had 87.99% of shares in the previous quarter but exited in the current quarter.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.120 | 0.120 | 5.05 | 5.07 | + 0.02 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.062 | 0.057 | 2.61 | 2.4 | -0.21 % |
Non Resident Indians (NRIs) | 0.012 | 0.017 | 0.49 | 0.71 | + 0.22 % |
Bodies Corporate | 0.073 | 0.065 | 3.09 | 2.76 | -0.33 % |
MONARCH NETWORTH FINSERVE PRIVATE LIMITED | 0 | 0.032 | 0 | 1.35 | +1.35% |
Any Other (specify) | 0.007 | 0.018 | 0.32 | 0.75 | + 0.43 % |
Bodies Corporate | 0.073 | 0.009 | 3.09 | 0.38 | -2.71 % |
HUF | 0.007 | 0.009 | 0.32 | 0.36 | + 0.04 % |
MONARCH NETWORTH FINSERVE PRIVATE | 0.032 | 0 | 1.35 | 0 | -1.35% |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.02 %.Observations show a significant difference of -0.21 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.22 %.Observations show a significant difference of -0.33 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.43 %.Observations show a significant difference of -2.71 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.04 %.MONARCH NETWORTH FINSERVE PRIVATE LIMITED had no shares in the previous quarter but now holds 1.35% of shares in the current quarter.MONARCH NETWORTH FINSERVE PRIVATE had 1.35% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Bafna Pharmaceuticals Limited “]